JP2016534022A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016534022A5 JP2016534022A5 JP2016503264A JP2016503264A JP2016534022A5 JP 2016534022 A5 JP2016534022 A5 JP 2016534022A5 JP 2016503264 A JP2016503264 A JP 2016503264A JP 2016503264 A JP2016503264 A JP 2016503264A JP 2016534022 A5 JP2016534022 A5 JP 2016534022A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- variable region
- set forth
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013158258 | 2013-07-30 | ||
| JP2013158258 | 2013-07-30 | ||
| PCT/JP2014/070661 WO2015016386A1 (en) | 2013-07-30 | 2014-07-30 | Medicament comprising anti-phospholipase d4 antibody |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018206702A Division JP2019014759A (ja) | 2013-07-30 | 2018-11-01 | 抗ホスホリパーゼｄ４抗体を含む医薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016534022A JP2016534022A (ja) | 2016-11-04 |
| JP2016534022A5 true JP2016534022A5 (enExample) | 2017-09-07 |
| JP6431523B2 JP6431523B2 (ja) | 2018-11-28 |
Family
ID=51493000
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016503264A Active JP6431523B2 (ja) | 2013-07-30 | 2014-07-30 | 抗ホスホリパーゼｄ４抗体を含む医薬 |
| JP2018206702A Ceased JP2019014759A (ja) | 2013-07-30 | 2018-11-01 | 抗ホスホリパーゼｄ４抗体を含む医薬 |
| JP2019173621A Active JP6843449B2 (ja) | 2013-07-30 | 2019-09-25 | 抗ホスホリパーゼｄ４抗体を含む医薬 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018206702A Ceased JP2019014759A (ja) | 2013-07-30 | 2018-11-01 | 抗ホスホリパーゼｄ４抗体を含む医薬 |
| JP2019173621A Active JP6843449B2 (ja) | 2013-07-30 | 2019-09-25 | 抗ホスホリパーゼｄ４抗体を含む医薬 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20160168266A1 (enExample) |
| EP (1) | EP3027656B1 (enExample) |
| JP (3) | JP6431523B2 (enExample) |
| KR (1) | KR102367760B1 (enExample) |
| CN (1) | CN105745226B (enExample) |
| AU (1) | AU2014297217B2 (enExample) |
| BR (1) | BR112016002001B1 (enExample) |
| CA (1) | CA2919736C (enExample) |
| DK (1) | DK3027656T3 (enExample) |
| ES (1) | ES2736324T3 (enExample) |
| HU (1) | HUE044469T2 (enExample) |
| MX (1) | MX381725B (enExample) |
| PL (1) | PL3027656T3 (enExample) |
| RU (1) | RU2709741C2 (enExample) |
| SG (2) | SG11201600666SA (enExample) |
| TR (1) | TR201910330T4 (enExample) |
| WO (1) | WO2015016386A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20210044A1 (ar) | 2010-12-30 | 2017-06-16 | Takeda Pharmaceuticals Co | الأجسام المضادة لـ cd38 |
| HUE054362T2 (hu) * | 2012-01-31 | 2021-09-28 | Sbi Biotech Co Ltd | Foszfolipáz D4 elleni antitest |
| SG11201600666SA (en) * | 2013-07-30 | 2016-02-26 | Sbi Biotech Co Ltd | Medicament comprising anti-phospholipase d4 antibody |
| MA45674A (fr) | 2016-07-15 | 2019-05-22 | Takeda Pharmaceuticals Co | Méthodes et matériaux permettant d'évaluer une réponse à des traitements de déplétion de plasmoblastes et de plasmocytes |
| MX2020007429A (es) | 2018-01-12 | 2020-10-15 | Takeda Pharmaceuticals Co | Dosificacion subcutanea de anticuerpos anti grupo de diferenciacion 38 (cd38). |
| JP7140367B2 (ja) * | 2018-05-31 | 2022-09-21 | 国立大学法人 東京大学 | ヒト由来サンプルにおける可溶型ｔｌｒ７の分析 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE139900T1 (de) * | 1992-11-13 | 1996-07-15 | Idec Pharma Corp | Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma |
| WO2000011015A1 (en) * | 1998-08-24 | 2000-03-02 | Alphagene, Inc. | Secreted proteins and polynucleotides encoding them |
| EP1392855A4 (en) * | 2000-12-07 | 2005-05-25 | Millennium Pharm Inc | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF VIRAL DISEASES VIA GENE 55092 |
| JP2013052781A (ja) | 2011-09-05 | 2013-03-21 | Tokai Rika Co Ltd | 車両用ミラー装置 |
| HUE054362T2 (hu) * | 2012-01-31 | 2021-09-28 | Sbi Biotech Co Ltd | Foszfolipáz D4 elleni antitest |
| SG11201600666SA (en) * | 2013-07-30 | 2016-02-26 | Sbi Biotech Co Ltd | Medicament comprising anti-phospholipase d4 antibody |
-
2014
- 2014-07-30 SG SG11201600666SA patent/SG11201600666SA/en unknown
- 2014-07-30 KR KR1020167002746A patent/KR102367760B1/ko active Active
- 2014-07-30 CN CN201480047721.6A patent/CN105745226B/zh active Active
- 2014-07-30 WO PCT/JP2014/070661 patent/WO2015016386A1/en not_active Ceased
- 2014-07-30 PL PL14761423T patent/PL3027656T3/pl unknown
- 2014-07-30 TR TR2019/10330T patent/TR201910330T4/tr unknown
- 2014-07-30 BR BR112016002001-4A patent/BR112016002001B1/pt active IP Right Grant
- 2014-07-30 SG SG10201800592SA patent/SG10201800592SA/en unknown
- 2014-07-30 MX MX2016001193A patent/MX381725B/es unknown
- 2014-07-30 AU AU2014297217A patent/AU2014297217B2/en active Active
- 2014-07-30 ES ES14761423T patent/ES2736324T3/es active Active
- 2014-07-30 EP EP14761423.4A patent/EP3027656B1/en active Active
- 2014-07-30 DK DK14761423.4T patent/DK3027656T3/da active
- 2014-07-30 RU RU2016106708A patent/RU2709741C2/ru active
- 2014-07-30 US US14/908,004 patent/US20160168266A1/en not_active Abandoned
- 2014-07-30 CA CA2919736A patent/CA2919736C/en active Active
- 2014-07-30 JP JP2016503264A patent/JP6431523B2/ja active Active
- 2014-07-30 HU HUE14761423 patent/HUE044469T2/hu unknown
-
2018
- 2018-11-01 JP JP2018206702A patent/JP2019014759A/ja not_active Ceased
-
2019
- 2019-09-25 JP JP2019173621A patent/JP6843449B2/ja active Active
-
2020
- 2020-12-18 US US17/127,202 patent/US20210130493A1/en not_active Abandoned